New Israeli-led AI model predicts chemotherapy benefit in breast cancer

Researchers from Technion and an international team have developed and validated a new AI model that can predict the benefit of chemotherapy in breast cancer patients using routine pathology samples, offering a fast and accessible alternative to genomic tests.